Distinct FAK-Src activation events promote α5β1 and α4β1 integrin-stimulated neuroblastoma cell motility Journal Article


Authors: Wu, L.; Bernard-Trifilo, J. A.; Lim, Y.; Lim, S. T.; Mitra, S. K.; Uryu, S.; Chen, M.; Pallen, C. J.; Cheung, N. K. V.; Mikolon, D.; Mielgo, A.; Stupack, D. G.; Schlaepfer, D. D.
Article Title: Distinct FAK-Src activation events promote α5β1 and α4β1 integrin-stimulated neuroblastoma cell motility
Abstract: Signals from fibronectin-binding integrins promote neural crest cell motility during development in part through protein-tyrosine kinase (PTK) activation. Neuroblastoma (NB) is a neural crest malignancy with high metastatic potential. We find that α4 and α5 integrins are present in late-stage NB tumors and cell lines derived thereof. To determine the signaling connections promoting either α4β1- or α5β1-initiated NB cell motility, pharmacological, dominant negative and short-hairpin RNA (shRNA) inhibitory approaches were undertaken. shRNA knockdown revealed that α5β1-stimulated NB motility is dependent upon focal adhesion kinase (FAK) PTK, Src PTK and p130Cas adapter protein expression. Cell reconstitution showed that FAK catalytic activity is required for α5β1-stimulated Src activation in part through direct FAK phosphorylation of Src at Tyr-418. Alternatively, α4β1-stimulated NB cell motility is dependent upon Src and p130Cas but FAK is not essential. Catalytically inactive receptor protein-tyrosine phosphatase-α overexpression inhibited α4β1-stimulated NB motility and Src activation consistent with α4-regulated Src activity occurring through Src Tyr-529 dephosphorylation. In α4 shRNA-expressing NB cells, α4β1-stimulated Src activation and NB cell motility were rescued by wild type but not cytoplasmic domain-truncated α4 re-expression. These studies, supported by results using reconstituted fibroblasts, reveal that α4β1-mediated Src activation is mechanistically distinct from FAK-mediated Src activation during α5β1-mediated NB migration and support the evaluation of inhibitors to α4, Src and FAK in the control of NB tumor progression. © 2008 Nature Publishing Group All rights reserved.
Keywords: controlled study; human tissue; protein phosphorylation; human cell; protein domain; enzyme activation; tumor cells, cultured; protein tyrosine kinase; wild type; neuroblastoma; neuroblastoma cell; enzyme analysis; cell movement; protein structure, tertiary; protein tyrosine phosphatase; protein dephosphorylation; tumor growth; cell activation; focal adhesion kinase; cell motility; motility; focal adhesion protein-tyrosine kinases; proto-oncogene proteins pp60(c-src); src; very late activation antigen 5; fak; very late activation antigen 4; α4 integrin; α5 integrin; integrin alpha4beta1; integrin alpha5beta1
Journal Title: Oncogene
Volume: 27
Issue: 10
ISSN: 0950-9232
Publisher: Nature Publishing Group  
Date Published: 2008-02-28
Start Page: 1439
End Page: 1448
Language: English
DOI: 10.1038/sj.onc.1210770
PUBMED: 17828307
PROVIDER: scopus
PMCID: PMC2593630
DOI/URL:
Notes: --- - "Cited By (since 1996): 31" - "Export Date: 17 November 2011" - "CODEN: ONCNE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Nai-Kong Cheung
    650 Cheung